Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

First 5G Life campus to open in Belgium

· Ericsson and Corda Campus set up Belgian 5G Life Campus in Hasselt to test 5G technologies across a range of innovative applications · New 5G Life Campus to welcome Belgian industry players to develop 5G applications that benefit industry and society, help boost the country’s economy and job market · The first 5G network environment in Belgium will be available first quarter of 2018, ahead of the expected commercial launch of the technology in the countryEricsson (NASDAQ: ERIC) and Corda Campus are launching the first 5G Life Campus in Hasselt, Belgium. The 5G Life Campus will be

Stockmann announces successful solicitation of consents regarding notes due 2018

STOCKMANN plc, Inside Information 29.11.2017 at 10:00 EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Stockmann plc (the “Issuer” or “Stockmann”) has successfully completed its consent solicitation (the “Consent Solicitation”) from all holders (the “Noteholders”) of its outstanding EUR 150 million 3.375 per cent notes due 2018 (ISIN: FI4000051057) (the "Notes") to approve certain modifications (the “Proposal”) to the terms and conditions of

Upbeat consumers see low risk of unemployment

The Economic Tendency Indicator climbed from 113.4 in October to 114.1 in November and points to much stronger growth than normal in the Swedish economy. All business sectors other than construction contributed to the rise. The consumer confidence indicator climbed for a second month, due mainly to a more positive view of the current state of their personal finances. Consumers also consider the risk of becoming unemployed to be at a 16-year low.The confidence indicator for the manufacturing industry rose from 121.2 in October to 121.9 in November and continues to show a very strong

Outotec received a grinding mill order from Southern Africa

OUTOTEC OYJ   PRESS RELEASE   NOVEMBER 29, 2017   AT 10:00 AM Outotec received a grinding mill order from Southern Africa Outotec has signed a contract with a major copper producer for the design and supply of two grinding mills, for their concentrator in Southern Africa. The order value, over EUR 10 million, has been booked in Outotec's 2017 fourth quarter order intake. Mills ordered for the project are a semi autogenous mill, and a ball mill, with associated ancillaries and installation supervisory services. Equipment will be delivered at end of 2018, for commissioning in early

Arise purchases bonds

Arise today announces that it has repurchased bonds with a remaining nominal value of SEK 51,900,000. The repurchase of bonds relates to the company’s secured bonds with a remaining nominal amount outstanding of SEK 951,500,000, incl. the volume now repurchased by Arise. The bonds have a floating rate corresponding to STIBOR 3m plus 3 percent and are due in April 2019 (ISIN: SE0005906849). The purchase price corresponds to 96 percent of the remaining outstanding nominal value of the bonds, i.e. approx. SEK 49,800,000. The purpose of the repurchase is to decrease gross debt and improve

NATTO: Private Placement in PharmaCo AS and start of Subscription Period

OSLO, NORWAY (29 November 2017) – Please find attached to this press release the Offering Memorandum and Subscription Form for the previously announced Private Placement in PharmaCo AS. The Subscription Period for the Private Placement is scheduled to start Wednesday November 29th 2017 at 09:00 hours CET, and will close on Tuesday December 12th 2017 at 13:00 hours CET. For more information, please contact: Kjetil Ramsøy, CFO, NattoPharma e-mail: kjetil.ramsoy@nattopharma.com  This information is subject to the disclosure requirements pursuant to section 5-12 of the

Interim Report   2017-01-01 - 2017-09-30

Summary of quarters 1, 2 and 3 (Q1, Q2, Q3), 2017 The following summary refers to the period 1/1/2017 – 30/9/2017, compared to 1/1/2016 – 30/9/2016  · Net sales for the first quarter totaled 0 SEK (0 SEK) · Operating result for the period of till -7 094 459 SEK (-4 920 324 SEK)* · Cash and bank balance 1 267 394 SEK (13 321 413 SEK SEK) · Capitalized development costs of 1 055 136 SEK (704 744 SEK) · Registered shares 9 805 714 (8 580 000) · Result per share -0,83 SEK (-0,57 SEK) · Equity Ratio 95 % (95 %) Summary of quarter 3 (Q3), 2017 The following summary

Addnode Group becomes even stronger in Design Management with the acquisition of MCAD

Symetri, an Addnode Group company, and the Nordic region's leading provider of software and services for design, data management and workflows, announced today that they have acquired MCAD Sverige AB (MCAD) with a turnover of approximately SEK 31 million.Since its foundation in 2003, MCAD has founded its offer in a broad understanding of manufacturing companies' design and manufacturing processes. The offer includes both services and products. Today, most of South Sweden's most well-known and successful manufacturing and process industries are found in the company's customer base. MCAD has

Climeon and German Heat Power operator signs a non-binding LOI.

Press release 29 November 2017 The German based Geoenergie Kirchweidach (GEK) and the Swedish clean tech company Climeon have today signed a non-binding LOI covering a supply of Climeon Heat Power modules to a geothermal power plant project in the Municipality of Kirchweidach. The potential order value is estimated to be about 5 MEUR.The LOI is based on Climeon’s patented Heat Power technology with record high efficiency in low temperatures that will utilize the excess heat of the geothermal plant that today delivers heat to a 20 hectares green house and the city of Kirchweidach. The

NextCell Pharma initiates stem cell trial for type 1-diabetes with ProTrans

NextCell Pharma AB ("NextCell") announces that the initiation meeting for the clinical trial in which drug candidate ProTrans will be evaluated, was held on November 28th, 2017. The trial will investigate safety as well as evaluate the patient’s own insulin production 12 months after receiving ProTrans stem cell treatment. Patients with type 1-diabetes being 18-40 years who received their diagnosis no later than 2 years ago and still have some insulin production are candidates for participation in the trial.NextCell Pharma has reached a new level as a company. I would like to thank all the

Fortum’s latest Energy Review: Towards a cleaner world with electromobility

ONLINE NEWS 29 November 2017Fortum today published its latest Energy Review, “Driving to a cleaner future”, which focuses on electromobility. The publication was done in connection with the E-mobility Exposed talks event in Haltia, Espoo. E-mobility is growing in the EU, and its progress in Europe is expected to keep up with the global pace. Fortum believes that the electrification of transport will take off rapidly. “We at Fortum believe that e-mobility can deliver a whole range of benefits, from cleaner air and less pollution to better energy usage. Electric vehicles (EVs) also

Enzymatica AB: Enzymatica's Nomination Committee for the Annual General Meeting 2018 appointed

PressreleaseLund 29 November 2017 Enzymatica's Nomination Committee for the Annual General Meeting 2018 appointed In accordance with the principles for the Nomination Committee established at the Annual General Meeting 2016, the Nomination Committee for the next Annual General Meeting shall consist of representatives of the four largest shareholders registered in the register of shareholders held by Euroclear Sweden AB as of 31 October each year, together with the Chairman of the Board, who shall also convene the Nomination Committee until its first meeting. The four largest

Obducat receives order from Prima Electro in Italy

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received an order from Prima Electro in Torino, Italy, for the supply of three systems, a QSC 200 RccTTM Coater, a QSS 200 Developer and an ELS 200 Etcher. The order value amounts to approx. 120 k€.Prima Electro is a Contract Electronics Manufacturing company based in Italy, that industrializes product ideas offering a turnkey service solution for a broad range of applications. Prima Electro is a full-service technology company and a leading player in the embedded product

Ahlsell acquires sprinkler businesses in Sweden and Finland

Ahlsell has signed an agreement with Doradus Capital AB to acquire their sprinkler businesses. The accumulated turnover of the acquired businesses is approximately 120 MSEK. Doradus Capital AB owns several sprinkler businesses and Ahlsell has decided to acquire Enexia AB, Enexia Oy, Prepipe Construction AB and Nordic Sprinkler AB. The geographical distribution of the turnover is about 2/3 Sweden and 1/3 Finland. The businesses will be integrated correspondingly into Ahlsell’s respective geographical segment. In Sweden, Sprinkler Nordic AB offers a full range of sprinkler components.

Changes to the composition of Humana’s Nomination Committee

As a consequence of the ownership changes that have taken place since Humana’s Nomination Committee was appointed in September 2017, the composition of the Nomination Committee has changed. Katarina Hammar representing Nordea Funds Ltd takes a seat on the Nomination Committee, while the representative from Bodenholm Capital AB resigns from the Nomination Committee.According to the principles for the appointment of the Nomination Committee, adopted by the AGM, the four largest shareholders as of August 31, who wish to participate in the Nomination Committee has the right to appoint one

Realfiction Holding AB: Offentliggör delårsrapport för januari – september 2017

Realfiction Holding AB (”Realfiction”) offentliggör härmed delårsrapporten för perioden januari – september 2017. Delårsrapporten i sin helhet bifogas som ett separat dokument och kan även laddas ner från bolaget webbplats (www.realfiction.com). Nedan följer en kort sammanfattning.Första tre kvartalen (2017-01-01 – 2017-09-30) · Intäkterna uppgick till 12,995 MSEK · Nettoresultatet efter finansiella poster uppgick till -5,934 MSEK · Resultat per aktie -0,60 SEK * · Soliditeten var 69,8% ** · Det operativa kassaflödet var -7,386 MSEK Tredje kvartalet (2017-07-01 – 2017-09-

NCC in consortium with Wayss & Freytag awarded phase of the West Link project for SEK 3.8 billion

The Swedish Transport Administration has selected NCC, in consortium with the German company Wayss & Freytag Ingeniurbau AG, to build the Korsvägen phase of the West Link project. The total order value is SEK 3.8 billion and the contract is expected to be signed in early December.The total contract consists of building the West Link tunnel, stretching from Landala, via Korsvägen, Örgryte/Jakobsdal to connect with existing tracks in Almedal. Construction start-up is planned for spring 2018 and the project is expected to run until 2026. The contract will be carried by NCC in consortium

Read original

Realfiction Holding AB: Announces Interim Report for January-September 2017

Realfiction Holding AB (”Realfiction”) hereby announces the Interim Report for the period January – September 2017. The full Interim Report is attached as a separate document and can also be downloaded from the company’s website (www.realfiction.com). Below is a brief summary of the Interim Report.Q1 – Q3 (2017-01-01 – 2017-09-30) · Revenue totalled SEK 12,995 million · Profit/(loss) after financial income and expenses, net amounted to SEK -5,934 million · Earnings per share * SEK -0,60 * · The solvency ratio was 69.8% ** · Cash flow from operating activities was SEK -

Anders Düring to take up position as CFO for Serneke

Anders Düring was appointed the new CFO for Serneke Group AB in July this year. On December 1, 2017, he will begin his role, take up his position in the Company's executive management and assume responsibility for Investor Relations.Anders was recruited to Serneke in July this year in order to contribute – with his many years of experience and extensive knowledge from listed companies – to the Serneke Group taking the next step in achieving its objectives. Prior this, he has been CFO at KappAhl (publ.) since 2013. Anders has also been previously active within Volvo IT and Ballingslöv.

OxThera Strengthens Patent Portfolio for treatment of Hyperoxaluria

OxThera AB announced today that it has recently been granted two new US patents, three new European patents and patents in Canada, China, Hong-Kong, India and Japan. OxThera now holds proprietary rights to pharmaceutical preparations and their use for treatment of hyperoxaluria in nine patent families. The newly granted US patents have numbers US8900575 and US8940295 covering pharmaceutical compositions of oxalate decarboxylase. The new European patents have numbers EP2449098 covering pharmaceutical compositions of oxalate decarboxylase, EP1771201 and EP1965816 covering pharmaceutical

UK's National Health Service signs GBP 22 million agreement for Elekta cancer treatment systems

NHS to upgrade radiation therapy capacity with several Elekta Synergy linear acceleratorsCRAWLEY, United Kingdom, November 29, 2017 – Elekta (EKTA-B.ST) announced today that it has signed a framework agreement with the National Health Service (NHS) Supply Chain to deliver several Elekta Synergy® digital accelerators, together with Agility™ multileaf collimators for high speed beam shaping and Elekta’s MOSAIQ® oncology information system. Steve Tomkins, Elekta’s Business Unit Manager for the UK and Nordics, says: “This new agreement provides NHS hospitals with greater opportunity to offer

Saga Tankers ASA :Q3 2017 financial results

(Oslo, 29 November 2017) Saga Tankers ASA ("Saga", OSE: SAGA) reported a net asset value (NAV) of NOK  403 million at the end of the third quarter of 2017, corresponding to NOK 1.51 per outstanding share, excluding minority interests and with Vallhall valued at book value. By the end of third quarter, Saga had a cash balance of NOK 63 million. All long term debt are related to the real estate in Vallhall (Saga's ownership is 55%). During the quarter the net change in market value of SD Standard Drilling Plc, Vistin Pharma ASA and Pareto Bank ASA  was negative NOK 6.85 million,

Democracy at a crossroads, according to new International IDEA report

29 November 2017 | GENEVA – Global democracy is at a crossroads and continuous actions must be taken to safeguard and protect it, according to the first edition of The Global State of Democracy publication from the International Institute for Democracy and Electoral Assistance (International IDEA), which was launched today at the United Nations Office at Geneva. The report finds that the world has experienced continued and steep democratic progress, however this progress has slowed down over the past decade, with challenges and threats emerging in specific countries and regions.

Multiconsult ASA – Repurchase of own shares

On 28 November 2017, Multiconsult ASA ("Multiconsult") purchased 500 of its own shares at an average price of NOK 71.50 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 437 296 of its own shares. For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

There are no items matching the current filter
There are no more items matching the current filter
Back to top